Thioacetamide induced liver damage in zebrafish embryo as a disease model for steatohepatitis

Journal of Biomedical Science

Volumn 13, Issue 2, 2006, Pages 225-232

  Amali, Aseervatham Anusha ^a   Rekha, Ravikumar Deepa ^a   Lin, Cliff Ji Fan ^a,b   Wang, Wei Lun ^a,c   Gong, Hong Yi ^a   Her, Gour Mour ^d   Wu, Jen Leih ^a  

^a INSTITUTE OF CELLULAR AND ORGANISMIC BIOLOGY   (Taiwan)

^b NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^d NATIONAL TAIWAN OCEAN UNIVERSITY   (Taiwan)

Author keywords

Liver; Steatosis; Thioacetamide; Zebrafish

Indexed keywords

ADIPONECTIN; CASPASE 3; CASPASE 8; MITOGEN ACTIVATED PROTEIN KINASE KINASE 4; PROTEIN BAD; PROTEIN BAX; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; SYNAPTOPHYSIN; THIOACETAMIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHEMOPROPHYLAXIS; EMBRYO; FATTY LIVER; HISTOLOGY; LIPID PEROXIDATION; LIVER INJURY; NICK END LABELING; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; UPREGULATION; ZEBRA FISH;

ANIMALS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; DISEASE MODELS, ANIMAL; EMBRYO, NONMAMMALIAN; FAT NECROSIS; HEPATITIS; LIVER DISEASES; THIOACETAMIDE; UP-REGULATION; ZEBRAFISH;

ANIMALIA; DANIO RERIO;

EID: 33645337369     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1007/s11373-005-9055-5     Document Type: Article

References (32)

1. Reid A.E., Nonalcoholic steatohepatitis. Gastroenterology. 121: 710-723, 2001.
2. Ledda-Columbano G.M., Coni P., Curto M., Giacomini L., Faa G., Oliverio S., Piacentini M. and Columbano A., Induction of two different modes of cell death, apoptosis and necrosis, in rat liver after a single dose of thioacetamide. Am. J. Pathol. 139: 1099-1109, 1991.
3. Muller D., Zimmerman S.I. and Schiller F., Drug metabolism in rat liver injured by thioacetamide. Arch. Toxicol. 5: 368-371, 1982.
4. Cruz A., Padillo F.J., Torres E., Navarrete C.M., Munoz-Castaneda J.R., Caballero F.J., Briceno J., Marchal T., Tunez I., Montilla P., Pera C. and Muntane J., Melatonin prevents experimental liver cirrhosis induced by thioacetamide in rats. J. Pineal Res. 39: 143-150, 2005.
5. Kuriyama S., Tsujimoto T., Nakatani Y., Tsujinoue H., Yoshiji H., Mitoro A., Yamazaki M., Okuda H., Toyokawa Y., Nagao S., Nishiwaki I. and Fukui H., Sonographic estimation of liver tumor development induced by oral administration of thioacetamide in rat. In Vivo. 3: 129-134, 1999.
6. Al-Bader A.A., Mathew T.C., Al-Mosawi M., Dashti H.M., Kumar D. and Singal P.K., Thioacetamide induced changes in trace elements and kidney damage. J. Trace Elem. Exp. Med. 12: 1-14, 2003.
7. Dashti H., Jeppsson B., Hagerstrand I., Hultberg B., Srinivas U., Abdulla M., Joelsson B. and Bengmark S., Early biochemical and histological changes in rats exposed to a single injection of thioacetamide. Pharmacol. Toxicol. 60: 171-174, 1987.
8. Gallagher C.H., Gupta D.N., Judah J.D. and Rees K.R., Biochemical changes in liver in acute thioacetamide intoxication. J. Pathol. Bacteriol. 72: 193-201, 1956.
9. Dashti H.M., Mathew T.C., Jadaon M.M. and Ashkanani E., Zinc and liver cirrhosis: biochemical and histopathologic assessment. Nutrition 13: 206-212, 1997.
10. Lee J.W., Shin K.D., Lee M., Kim E.J., Han S.S., Han M.Y., Ha H., Jeong T.C. and Koh W.S., Role of metabolism by flavin-containing monooxygenase in thioacetamide-induced immunosuppression. Toxicol. Lett. 136: 163-172, 2003.
11. Barker E.A. and Smuckler E.A., Altered microsome function during acute thioacetamide poisoning. Mol. Pharmacol. 8: 318-326, 1972.
12. Morley C.G. and Boyer J.L., Stimulation of hepatocellular proliferation by a serum factor from thioacetamide-treated rats. Biochim. Biophys. Acta. 477: 165-176, 1977.
13. Her G.M., Chiang C.C., Chen W.Y. and Wu J.L., In vivo studies of liver-type fatty acid binding protein (L-FABP) gene expression in liver of transgenic zebrafish (Danio rerio). FEBS Lett. 538: 125-133, 2003.
14. Her G.M., Yeh Y.H. and Wu J.L., 435-bp liver regulatory sequence in the liver fatty acid binding protein (L-FABP) gene is sufficient to modulate liver regional expression in transgenic zebrafish. Dev. Dyn. 227: 347-356, 2003.
15. Westerfield M., The Zebrafish Book: A Guide for the Laboratory Use of Zebrafish (Danio rerio), 2nd ed., University of Oregon Press, Eugene, 1994.
16. Ramaiah S.K., Apte U. and Mehendale H.M., Cytochrome P4502E1 induction increases thioacetamide liver injury in dietrestricted rats. Drug Metab. Dispos. 29: 1088-1095, 2001.
17. Hunter A.L., Holscher M.A. and Neal R.A., Thioactamide induced hepatic necrosis. Involvement of the mixed function oxidase enzyme system. J. Pharmacol. Exp. Ther. 200: 439-448, 1977.
18. Witzma F.A., Fultz C.D., Mangipudy R.S. and Mehendale H.M., Two-dimensional electrophoretic analysis of compartment-specific hepatic protein charge modification induced by thioacetamide exposure in rats. Fundam. Appl. Toxicol. 31: 124-132, 1996.
19. Martin H., Sarsat J.P., deWaziers I., Housset C., Balladur P., Beaune P., Albaladejo V. and Lerche-Langrand C., Induction of cytochrome P450 2B6 and 3A4 expression by Phenobarbital and cyclophosphamide in cultured human liver slices. Pharm. Res. 20: 557-568, 2003.
20. Meredith C., Scott M.P., Renwick A.B., Price R.J. and Lake B.C., Studies on the induction of rat hepatic CYP1A, CYP2B, CYP3A and CYP4A subfamily form mRNAs in vivo and in vitro using precision-cut rat liver slices. Xenobiotica 33: 511-527, 2003.
21. Chieli E. and Malvadi G., Role of Cyt P-450 dependent and FAA containing mono oxygenases in the bioactivation of thioacetamide, thiobezamide and their sulophoxides. Biochem. Pharmacol. 34: 395-396, 1985.
22. Ambrose A.M., DeEds F. and Rather L.J., Toxicity of thioacetamide in rats. J. Indian Hygiene Toxicol. 31: 158-161, 1949.
23. Neal R.A. and Halpert J., Toxicology of thionosulfer compounds. Annu. Rev. Pharmacol. Toxicol. 22: 321-339, 1982.
24. Unger R.H. and Orci L., Lipoapoptosis: its mechanism and its diseases. Biochim. Biophy. Acta. 1585: 202-212, 2002.
25. Marchesini G., Brizi M., Morselli-Labate A.M. et al., Association of non lcoholic fatty liver disease with insulin resistance. Am. J. Med. 107: 450-455, 1999.
26. Shimomura I., Bashmakov Y., Ikemoto S., Horton J.D., Brown M.S. and Goldstein J.L., Insulin selectively increases SREBP-1c mRNA in the livers of rats with treptozotocin-induced diabetes. Proc. Natl. Acad. Sci. USA. 96: 13656-13661, 1999.
27. Foretz M., Guichard C., Ferre P. and Foufelle F., Sterol regulatory element binding protein-1c is a major mediator of insulin action on the hepatic expression of glucokinase and lipogenesis-related genes. Proc. Natl. Acad. Sci. USA. 96: 12737-12742, 1999.
28. Horton J.D., Goldstein J.L. and Brown M.S., SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J. Clin. Invest. 109: 1125-1131, 2002.
29. Robertson G., Leclercq I. and Farrell G.C., Nonalcoholic steatosis and steatohepatitis: II. Cytochrome P-450 enzymes and oxidative stress. Am. J. Physiol. Gastrointest. Liver Physiol. 281: G1135-G1139, 2001.
30. Davila J.C., Lenherr A. and Acosta D., Protective effects of flavonoids on drug induced hepatotoxicity. Toxicology 57: 267-268, 1989.
31. Reddy J.K. and Hashimoto T., Peroxisomal beta-oxidation and peroxisome proliferator-activated receptor alpha: an adaptive metabolic system. Annu. Rev. Nutr. 21: 193-230, 2001.
32. Gonzalez F.J., Peters J.M. and Carttley R.C., Mechanism of action of the nongenotoxic peroxysome proliferators activator receptor alpha. J. Natl. cancer Inst. 90: 1702-1709, 1998.